Lymphatic Drainer (Newton Laboratories, Inc.)
Welcome to the PulseAid listing for the Lymphatic Drainer drug offered from Newton Laboratories, Inc.. This Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Seed Storage Proteins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Newton Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Asterias rubens, Aur. met.,Belladonna, Benzoicum acidum, Berber. vulg., Bryonia, Calc. carb., Cantharis, Ceanothus, Chelidonium majus Chionanthus virginica, Cinchona, Dioscorea ,Iris versicolor, Nat. |
| SUBSTANCE NAME: | ASTERIAS RUBENS; GOLD; ATROPA BELLADONNA; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; LYTTA VESICATORIA; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Seed Storage Proteins [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | PELLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2011-06-01 |
| END MARKETING DATE: | 0000-00-00 |
Lymphatic Drainer HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lymphatic Drainer from Newton Laboratories, Inc. |
| LABELER NAME: | Newton Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 3; 3; 3; 3([hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; ) |
| START MARKETING DATE: | 2011-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55714-4545_2a41ae1d-563d-5e45-2ae4-28b59421ca59 |
| PRODUCT NDC: | 55714-4545 |
| APPLICATION NUMBER: | |
Other ASTERIAS RUBENS; GOLD; ATROPA BELLADONNA; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; LYTTA VESICATORIA; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM Pharmaceutical Manufacturers / Labelers:
